Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning and AI algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine. Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.
| Website | http://www.recursion.com |
| Revenue | $48.6 million |
| Employees | 762 (0 on RocketReach) |
| Founded | 2013 |
| Address | 41 S Rio Grande St, Salt Lake City, Utah 84101, US |
| Industry | Biotechnology Research |
| Keywords | Drug Discovery, Biotechnology, Healthcare, Technology, Pharmaceutical, Therapeutics, Clinical Stage, Automation, Research, Development, Data Science, Chemistry, Biology, Artificial Intelligence, Engineering, Precision Medicine, Machine Learning, Genomics, Bioinformatics, Big Data |
| Competitors | CureVac, Zymergen, Inc., Schrödinger, BenevolentAI, Insilico Medicine, Atomwise, BioAge Labs, NervGen Pharma Corp., Reciprocal , Inc., Geno +31 more (view full list) |
Looking for a particular Recursion employee's phone or email?
The Recursion annual revenue was $48.6 million in 2026.
Recursion is based in Salt Lake City, Utah.